Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community. - Wikidata - awgldk - TriplyDB

Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community.

Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community.

http://www.wikidata.org/entity/Q34980239

about

Evolution of target organ damage and haemodynamic parameters over 4 years in patients with increased insulin resistance: the LOD-DIABETES prospective observational study Performance of Sokolow-Lyon index in detection of echocardiographically diagnosed left ventricular hypertrophy in a normal Eastern German population - results of the CARLA study.Screening for coronary artery disease in patients with type 2 diabetes mellitus: An evidence-based review Yearly evolution of organ damage markers in diabetes or metabolic syndrome: data from the LOD-DIABETES study.Features of left ventricular hypertrophy in patients with metabolic syndrome with or without comparable blood pressure: a meta-analysis.Updating experimental models of diabetic cardiomyopathy Electrocardiographic Left Ventricular Hypertrophy Among Gambian Diabetes Mellitus Patients.Gender differences in the progression of target organ damage in patients with increased insulin resistance: the LOD-DIABETES study Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3β-PP2Ac-NF-κB Signaling Axis.Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.Cardiac fibrosis and down regulation of GLUT4 in experimental diabetic cardiomyopathy are ameliorated by chronic exposures to intermittent altitude Prevalence, types and factors associated with echocardiographic abnormalities among newly diagnosed diabetic patients at Mulago Hospital Blood pressure control in type 2 diabetic patients.DPP4 inhibitors and cardiovascular outcomes: safety on heart failure.Higher prevalence of left ventricular hypertrophy in two Māori cohorts: findings from the Hauora Manawa/Community Heart Study.Troxerutin reverses fibrotic changes in the myocardium of high-fat high-fructose diet-fed mice.Evidence for a Specific Diabetic Cardiomyopathy: An Observational Retrospective Echocardiographic Study in 656 Asymptomatic Type 2 Diabetic Patients LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.Role of Vitamin D in Cardiovascular Diseases.Pregestational type 2 diabetes mellitus induces cardiac hypertrophy in the murine embryo through cardiac remodeling and fibrosis.Type 2 diabetes mellitus-related changes in left ventricular structure and function in patients with chronic kidney disease.Impact of fasting glucose on electrocardiographic left ventricular hypertrophy in an elderly general population.Diabetes and Associated Cardiovascular Complications in American Indians/Alaskan Natives: A Review of Risks and Prevention Strategies

P2860

Q24658535-BA125F28-E722-4C71-BF32-58897805C111 Q30316384-0312DF46-729E-4C35-995F-CC5CB6DD2E07 Q30471287-448E32BF-CD5D-4EBC-BF96-4ABECEF408FC Q34048212-43ACB8D6-D624-4F05-BC58-E4683879E429 Q34570641-A5F913DB-51B6-4631-98DF-E3EBBD59F8CE Q35564129-1BAB4245-91FD-488E-B6DB-6E92C46CE19E Q35996797-F6AE63CF-79BB-4EB4-A890-49A36E67696D Q36115002-80A8D0E7-641C-4DBB-82BA-A7AAC2360A72 Q36194161-841642C7-4939-460B-9840-072D5E371982 Q36320281-26F46C6E-5361-4595-B3E6-A18511DD6872 Q36785456-50C33228-A1F4-4DEA-A596-E71549FC88F3 Q37025209-67F6016E-EF59-4B5C-841C-A91EC49231F9 Q37566950-07603F8A-7FF7-4A24-A549-C87305079438 Q38833312-52E94A7B-399B-43FB-9BA9-CB299FCEE9EA Q40247281-BD9D7911-91D4-4F68-9FA0-8DBD0F45638B Q40832697-753149C2-4713-40A3-A711-A9E14D7145BF Q41108730-F96A1474-4F85-4396-9F6B-27D13D61320B Q41440898-2655B210-24C8-404E-B86F-85760EDE912D Q46209230-3A49C8AD-A93D-4958-8BDB-C6019CFA9DD4 Q47793229-52B1B989-9A07-4AB1-850D-FE064731B8FF Q51244376-0F9FE9DA-5542-4D87-B723-A12EF5743D28 Q51304491-EDD9AFDC-AB0B-4073-B211-C39B697254AB Q57300404-F18E6E55-3C3F-420F-94ED-D6A7C3FD61F3

P2860

Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community.

http://www.wikidata.org/entity/Q34980239

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Screening for left ventricular ...... tes mellitus in the community.

@ast

Screening for left ventricular ...... tes mellitus in the community.

@en

Screening for left ventricular ...... tes mellitus in the community.

@nl

type

label

Screening for left ventricular ...... tes mellitus in the community.

@ast

Screening for left ventricular ...... tes mellitus in the community.

@en

Screening for left ventricular ...... tes mellitus in the community.

@nl

prefLabel

Screening for left ventricular ...... tes mellitus in the community.

@ast

Screening for left ventricular ...... tes mellitus in the community.

@en

Screening for left ventricular ...... tes mellitus in the community.

@nl

P1433

Q34980239-1339B6A1-E7C7-4D66-9B4F-7AC131EF53EE

P1476

Q34980239-2876D1F1-2C8F-443B-9A0C-194A63E2D077

P2093

Q34980239-50357DCA-8E38-47B5-BABD-19D7307B7296

Q34980239-CCD861B0-F1C1-40A6-8E6B-4F6FD580866A

Q34980239-D483F497-2CAB-4B63-9B42-952BF5F87845

Q34980239-D897DE02-8487-40EB-924D-EC9C873E678D

Q34980239-DC702B30-2441-4C06-8E33-DF5623A9EE12

P2860

Q34980239-168BA13A-BFF3-4B12-8F90-14111211EDD4

Q34980239-17984167-B9B5-49F1-9AE0-A156B4E713C9

Q34980239-1C8454D7-D271-44C8-B7AE-C5E27CF19AB9

Q34980239-2502B7FD-95C4-4312-ABA8-981E8F22E8B2

Q34980239-2E1C8F5D-35ED-460B-BF51-B47C699D0B56

Q34980239-34AF6821-A48D-456C-A6BE-E4A29B77F8AE

Q34980239-3B1C8977-87BB-47D2-9E16-CE587149DD70

Q34980239-4B19BB48-C2C7-44D0-B1C6-68AEA715E9D0

Q34980239-5B4FCEA9-D4B3-49A0-AD7F-B41D405301D4

Q34980239-5E0794A2-2156-418A-8EFB-561FFD47E2B4

P2888

Q34980239-15A50CC5-70F3-4EA8-A6DC-0E03A31FFE6E

P304

Q34980239-95D1BFF7-E351-40E4-ADD2-9ECE487C88F3

P31

Q34980239-4133DD78-17A9-4F53-8C14-3DED2D133FAB

P356

Q34980239-69DD099C-374D-4DCC-B161-A3518CF851F8

P407

Q34980239-89147767-B7C5-481D-BEF5-A2E476362CAB

P478

Q34980239-B2177004-E349-4A6E-BB36-729D3F65DDAA

P50

Q34980239-13E0EE44-46A2-4696-8015-A77141E32BDA

Q34980239-C2758249-1EAF-4252-85E4-276470A4C909

Q34980239-F254B26C-2E7A-4E5B-A056-455F1FA26B94

P577

Q34980239-6AC559C2-2AC8-47CE-AD42-35C38753206A

P5875

Q34980239-E3F49AA7-BD2A-4CE6-AA05-2A2436BA4B01

P6179

Q34980239-370B55BC-30CA-4CF8-A983-2C9794876A2D

P698

Q34980239-7EDD3600-A28B-4650-83A4-25CE5B96D194

P921

Q34980239-0C742B5B-F3F9-4F22-83D1-8317ACE85BD5

Q34980239-B8238E17-D264-407B-B80A-10C93C68D1D5

P932

Q34980239-DDBF0635-1D28-43D7-B5D2-42D641B8CD52

P356

1475-2840-10-29

P1433

Cardiovascular Diabetology

P1476

Screening for left ventricular ...... etes mellitus in the community

@en

P2093

Ann Pearl

http://www.w3.org/2001/XMLSchema#string

Gina Wadams

http://www.w3.org/2001/XMLSchema#string

Katrina K Poppe

http://www.w3.org/2001/XMLSchema#string

Rob N Doughty

http://www.w3.org/2001/XMLSchema#string

Warwick Bagg

http://www.w3.org/2001/XMLSchema#string

P2860

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients.

Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides.

Standards of medical care in diabetes--2007.

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial.

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Left ventricular dysfunction screening in hypertensive patients with N-terminal pro-B-type natriuretic peptide and electrocardiogram.

Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study.

P2888

1475-2840-10-29

P304

29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-10-29

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Gillian A. Whalley

Jithendra Somaratne

Mariska M ter Bals

P577

2011-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51050709

http://www.w3.org/2001/XMLSchema#string

P6179

1024387654

http://www.w3.org/2001/XMLSchema#string

P698

21492425

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3094210

http://www.w3.org/2001/XMLSchema#string